Home › Funds › Millennium Management › CPRX
Millennium Management position in CPRX
CATALYST PHARMACEUTICALS INC
Latest position (Q2 2026)1.07M sh
Reported value held$33.59M
Portfolio Weight0.01%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 54.19K | $287.00K | New |
| Q4 2021 | 231.43K | $1.57M | Add |
| Q1 2022 | 1.16M | $9.65M | Add |
| Q2 2022 | 2.72M | $19.09M | Add |
| Q3 2022 | 1.44M | $18.48M | Reduce |
| Q4 2022 | 2.31M | $43.03K | Add |
| Q1 2023 | 1.36M | $22.47K | Reduce |
| Q2 2023 | 315.06K | $4.23M | Reduce |
| Q3 2023 | 340.27K | $3.98M | Add |
| Q4 2023 | 178.72K | $3.00M | Reduce |
| Q1 2024 | 104.54K | $1.67M | Reduce |
| Q2 2024 | 129.81K | $2.01M | Add |
| Q3 2024 | 559.77K | $11.13M | Add |
| Q4 2024 | 520.78K | $10.87M | Reduce |
| Q1 2025 | 303.53K | $7.36M | Reduce |
| Q2 2025 | 430.13K | $9.33M | Add |
| Q3 2025 | 1.37M | $26.90M | Add |
| Q4 2025 | 993.65K | $23.19M | Reduce |
| Q1 2026 | 786.99K | $19.49M | Reduce |
| Q2 2026 | 1.07M | $33.59M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding CPRX
- BlackRock Inc 19.16M sh · $602.16M · Q2 2026
- Vanguard Group 8.43M sh · $196.81M · Q4 2025
- JPMorgan Chase & Co 3.17M sh · $99.89M · Q2 2026
- Geode Capital Management 3.15M sh · $99.03M · Q2 2026
- Morgan Stanley 2.76M sh · $86.76M · Q2 2026
- Renaissance Technologies 2.14M sh · $67.14M · Q2 2026
- Janus Henderson Group 2.00M sh · $49.52M · Q1 2026
- UBS Group AG 1.45M sh · $45.69M · Q2 2026
- Northern Trust Corp 1.33M sh · $41.82M · Q2 2026
- Bank of America Corp 1.31M sh · $41.22M · Q2 2026
- Goldman Sachs Group 1.19M sh · $37.53M · Q2 2026
- Charles Schwab Investment Management 1.16M sh · $36.44M · Q2 2026